Skip to main content

ADVERTISEMENT

Gillian Anderson

Abstract: Introduction: There is evidence that insomnia patients with objective short-sleep duration (I-SSD; total sleep time [TST]
01/19/2023
Abstract: Introduction: There is a well-established reciprocal relationship between pain and poor sleep. Therefore, it is clinically important to evaluate whether a sleep-promoting drug s...
01/19/2023
Abstract: Introduction: Headache is a frequently reported treatment-emergent adverse event (TEAE) in clinical trials of hypnotics. We evaluated the frequency and timing of TEAEs of headac...
01/19/2023
Abstract: Introduction: Study E2006-G000-303 (Study 303; NCT02952820) showed lemborexant (LEM) provided significant benefit vs placebo (PBO) on patient-reported sleep and fatigue severity...
01/19/2023
Abstract: Introduction: A concern with sedative-hypnotic medication for the treatment of insomnia is the development of tolerance. The Patient Global Impression–Insomnia (PGI-I) and Insom...
01/19/2023
Abstract: Introduction: Abnormal dreams and nightmares are reported by patients with insomnia both before and after treatment with hypnotics. Dual orexin receptor antagonists such as lemb...
01/19/2023